03/05/2015 - Reviews
MDR-ABC transporters: biomarkers in rheumatoid arthritis
Márki-Zay J, Tauberné Jakab K, Szerémy P, Krajcsi P. Clinical and Experimental Rheumatology 2013 May 27. [Epub ahead of print]
Abstract
MDR-ABC transporters are widely expressed in cell types relevant to pathogenesis of rheumatoid arthritis. Many reports demonstrate the interaction of small molecule drugs with MDR-ABC transporters. Cell-based assays for disease relevant cell types can be easily gated and could reveal specific drug targets and may increase significance and utilisation of data in clinical practice. Many commonly used DMARDs (e.g. methotrexate, sulfasalazine, leflunomide/teriflunomide, hydroxychloroquine) are ABCG2 substrates. Consequently, the activity of this transporter in patients should be determined to understand the disposition and pharmacokinetics of the therapy. In addition, MDR-ABC transporters transport a variety of endobiotics that play important roles in cell proliferation, cell migration, angiogenesis and inflammation. Therefore, MDR-ABC transporters are important biomarkers in rheumatoid arthritis.
open_in_new Read the Source
Next: Membrane Transporters in Physiological Barriers of Pharmacological Importance
Previous: Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions
